In vitro anti-HIV-1 synergy between non-nucleoside reverse transcriptase inhibitors nevirapine and efavirenz

被引:0
|
作者
Kollmann, C
Tremblay, C
Giguel, F
Chou, TC
Hirsch, MS [1 ]
机构
[1] Massachusetts Gen Hosp, Boston, MA 02114 USA
[2] Harvard Univ, Sch Med, Boston, MA USA
[3] Harvard Univ, Program Virol, Boston, MA USA
[4] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
下载
收藏
页码:143 / 144
页数:2
相关论文
共 50 条
  • [21] Conformational preferences of non-nucleoside HIV-1 reverse transcriptase inhibitors
    Parreira, RLT
    Abrahao, O
    Galembeck, SE
    TETRAHEDRON, 2001, 57 (16) : 3243 - 3253
  • [22] Design and anti-HIV activity of arylsulphonamides as non-nucleoside reverse transcriptase inhibitors
    Singh, Anuradha
    Yadav, Madhu
    Srivastava, Ritika
    Singh, Nidhi
    Kaur, Rajinder
    Gupta, Satish K.
    Singh, Ramendra K.
    MEDICINAL CHEMISTRY RESEARCH, 2016, 25 (12) : 2842 - 2859
  • [23] Optimization of diarylamines as non-nucleoside inhibitors of HIV-1 reverse transcriptase
    Ruiz-Caro, J
    Basavapathruni, A
    Kim, JT
    Bailey, CM
    Wang, LG
    Anderson, KS
    Hamilton, AD
    Jorgensen, WL
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2006, 16 (03) : 668 - 671
  • [24] HIV-1 reverse transcriptase resistance to non-nucleoside inhibitors.
    Spence, RA
    Johnson, KA
    BIOPHYSICAL JOURNAL, 1996, 70 (02) : MP356 - MP356
  • [25] Novel benzophenones as non-nucleoside reverse transcriptase inhibitors of HIV-1
    Chan, JH
    Freeman, GA
    Tidwell, JH
    Romines, KR
    Schaller, LT
    Cowan, JR
    Gonzales, SS
    Lowell, GS
    Andrews, CW
    Reynolds, DJ
    St Clair, M
    Hazen, RJ
    Ferris, RG
    Creech, KL
    Roberts, GB
    Short, SA
    Weaver, K
    Koszalka, GW
    Boone, LR
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (05) : 1175 - 1182
  • [26] Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
    Famiglini, Valeria
    Silvestri, Romano
    MOLECULES, 2016, 21 (02):
  • [27] Computer-aided design of potential anti-HIV-1 non-nucleoside reverse transcriptase inhibitors by contraction of β-ring in TIBO derivatives
    Hemmateenejad, B
    Tabaei, SMH
    Namvaran, F
    JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM, 2005, 732 (1-3): : 39 - 45
  • [28] Halolactones are potent HIV-1 non-nucleoside reverse transcriptase inhibitors
    Han, Xin
    Wu, Haoming
    Dong, Chune
    Tien, Po
    Xie, Wei
    Wu, Shuwen
    Zhou, Hai-Bing
    RSC ADVANCES, 2015, 5 (13): : 10005 - 10013
  • [29] Design and anti-HIV activity of arylsulphonamides as non-nucleoside reverse transcriptase inhibitors
    Anuradha Singh
    Madhu Yadav
    Ritika Srivastava
    Nidhi Singh
    Rajinder Kaur
    Satish K. Gupta
    Ramendra K. Singh
    Medicinal Chemistry Research, 2016, 25 : 2842 - 2859
  • [30] Treatment of HIV-infected patients with a combination of efavirenz, nevirapine and nucleoside reverse transcriptase inhibitors
    Arranz-Caso, J
    Gorgolas, M
    Estrada, V
    Garcia-Diaz, JD
    HIV MEDICINE, 2004, 5 (02) : 128 - 129